Correct
Target pigmentation, melasma and uneven skin tone through evidence-based actives selected for clinical efficacy and cutaneous tolerance.
Clinically inspired skincare developed to address pigmentation, healthy skin aging and skin barrier resilience through evidence-based formulation.

Target pigmentation, melasma and uneven skin tone through evidence-based actives selected for clinical efficacy and cutaneous tolerance.
Strengthen the skin barrier with ceramide, lipid and peptide systems formulated to reinforce structural resilience and hydration.
Support healthy skin aging through measured, well-characterised molecules — never marketing hype, never unsupported claims.
VIREL formulates using evidence-based ingredients selected for efficacy, compatibility and skin tolerance.
We do not chase seasonal trends. We do not manufacture claims. Every actives system is chosen for a measurable clinical rationale — and every formula is documented at concentrations aligned with the published literature on cutaneous efficacy and safety.
A working scientific database of the molecules VIREL formulates with — mechanisms, documented concentration ranges and clinical context.
Barrier + pigment modulation
Plasmin-pathway pigment control
Tyrosinase-inhibiting brightener
Signal + carrier complexes
Lipophilic exfoliant
NP / AP / EOP barrier lipids

The first VIREL formulations focus on pigmentation correction — a complete morning-and-night protocol.
Serum · 30 ml
Day Cream · 50 ml
Night Cream · 50 ml
Eye Cream · 15 ml
Cleanser · 150 ml
Access to formulation dossiers, ingredient monographs and research correspondence for dermatologists, clinicians, manufacturers, ingredient innovators and researchers.
Professional EnquiriesPrecision, transparency and clinical restraint — the standard we hold every formulation to.
